Orrù Christina D, Groveman Bradley R, Hughson Andrew G, Manca Matteo, Raymond Lynne D, Raymond Gregory J, Campbell Katrina J, Anson Kelsie J, Kraus Allison, Caughey Byron
Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, 903 S. 4th St., Hamilton, MT, 59840, USA.
Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, 903 South 4th Street, Hamilton, MT, 59840, USA.
Methods Mol Biol. 2017;1658:185-203. doi: 10.1007/978-1-4939-7244-9_14.
In coping with prion diseases, it is important to have tests that are practical enough for routine applications in medicine, agriculture, wildlife biology, and research, yet sensitive enough to detect minimal amounts of infectivity. Real-time quaking-induced conversion (RT-QuIC) assays have evolved to the point where they fulfill these criteria in applications to various human and animal prion diseases. For example, RT-QuIC assays of cerebrospinal fluid and nasal brushings allow for highly sensitive (77-97%) and specific (99-100%) identification of human sCJD patients. Recent improvements have markedly enhanced sensitivity and reduced the assay time required for many samples to a matter of hours rather than days. By combining analyses of cerebrospinal fluid and nasal brushings, diagnostic sensitivities and specificities of nearly 100% can be achieved. RT-QuIC assays are based on prion-seeded amyloid fibril formation by recombinant prion protein (rPrP) in multiwell plates using a Thioflavin T fluorescence readout. Here we describe our current RT-QuIC methodologies as well as technical considerations in executing, troubleshooting, and adapting the assay to new strains of prions and sample types.
在应对朊病毒疾病时,拥有足够实用、可用于医学、农业、野生动物生物学及研究领域常规检测,且灵敏到足以检测出微量传染性的检测方法至关重要。实时震颤诱导转化(RT-QuIC)检测技术已经发展到在应用于各种人类和动物朊病毒疾病时能够满足这些标准的程度。例如,脑脊液和鼻拭子的RT-QuIC检测能够高度灵敏(77%-97%)且特异(99%-100%)地鉴定人类散发性克雅氏病(sCJD)患者。最近的改进显著提高了灵敏度,并将许多样本所需的检测时间从数天缩短至数小时。通过结合脑脊液和鼻拭子的分析,诊断灵敏度和特异性可接近100%。RT-QuIC检测基于重组朊病毒蛋白(rPrP)在多孔板中通过硫黄素T荧光读数进行朊病毒种子淀粉样纤维形成。在此,我们描述了当前的RT-QuIC方法,以及在执行、故障排除和使该检测适应新的朊病毒株和样本类型时的技术考量。